255 related articles for article (PubMed ID: 21672190)
1. Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study.
Iribarren C; Phelps BH; Darbinian JA; McCluskey ER; Quesenberry CP; Hytopoulos E; Vogelman JH; Orentreich N
BMC Cardiovasc Disord; 2011 Jun; 11():31. PubMed ID: 21672190
[TBL] [Abstract][Full Text] [Related]
2. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
3. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Lee KW; Lip GY; Blann AD
Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
[TBL] [Abstract][Full Text] [Related]
4. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis.
Tuo QH; Zeng H; Stinnett A; Yu H; Aschner JL; Liao DF; Chen JX
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2547-57. PubMed ID: 18408125
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
Leinonen E; Wathén KA; Alfthan H; Ylikorkala O; Andersson S; Stenman UH; Vuorela P
J Clin Endocrinol Metab; 2010 Jan; 95(1):126-33. PubMed ID: 19875484
[TBL] [Abstract][Full Text] [Related]
6. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
[TBL] [Abstract][Full Text] [Related]
7. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
Caine GJ; Blann AD; Stonelake PS; Ryan P; Lip GY
Eur J Clin Invest; 2003 Oct; 33(10):883-90. PubMed ID: 14511360
[TBL] [Abstract][Full Text] [Related]
8. The contribution of dietary and plasma folate and cobalamin to levels of angiopoietin-1, angiopoietin-2 and Tie-2 receptors depend on vascular endothelial growth factor status of primary breast cancer patients.
Pirouzpanah S; Varshosaz P; Fakhrjou A; Montazeri V
Sci Rep; 2019 Oct; 9(1):14851. PubMed ID: 31619709
[TBL] [Abstract][Full Text] [Related]
9. Elevated plasma thrombomodulin and angiopoietin-2 predict the development of acute kidney injury in patients with acute myocardial infarction.
Liu KL; Lee KT; Chang CH; Chen YC; Lin SM; Chu PH
Crit Care; 2014 May; 18(3):R100. PubMed ID: 24886544
[TBL] [Abstract][Full Text] [Related]
10. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
[TBL] [Abstract][Full Text] [Related]
11. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
12. Circulating angiopopietin-1 correlates with the clinical course of multiple organ dysfunction syndrome and mortality in patients with severe sepsis.
Lin SM; Chung FT; Kuo CH; Chou PC; Wang TY; Chang PJ; Lo YL; Huang CD; Lin HC; Wang CH; Kuo HP
Medicine (Baltimore); 2015 May; 94(20):e878. PubMed ID: 25997069
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentration of angiopoietin-1, angiopoietin-2 and Tie-2 in cervical cancer.
Kopczyńska E; Makarewicz R; Biedka M; Kaczmarczyk A; Kardymowicz H; Tyrakowski T
Eur J Gynaecol Oncol; 2009; 30(6):646-9. PubMed ID: 20099495
[TBL] [Abstract][Full Text] [Related]
14. Plasma angiopoietin-1 level, left ventricular ejection fraction, and multivessel disease predict development of 1-year major adverse cardiovascular events in patients with acute ST elevation myocardial infarction - a pilot study.
Liu KL; Lin SM; Chang CH; Chen YC; Chu PH
Int J Cardiol; 2015 Mar; 182():155-60. PubMed ID: 25577775
[TBL] [Abstract][Full Text] [Related]
15. Circulating angiopoietin and Tie-2 levels in systemic sclerosis.
Dunne JV; Keen KJ; Van Eeden SF
Rheumatol Int; 2013 Feb; 33(2):475-84. PubMed ID: 22461185
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.
Patel JV; Lim HS; Varughese GI; Hughes EA; Lip GY
Ann Med; 2008; 40(3):215-22. PubMed ID: 18382887
[TBL] [Abstract][Full Text] [Related]
17. The role of biomarkers of endothelial activation in predicting morbidity and mortality in patients with severe sepsis and septic shock in intensive care: A prospective observational study.
Fang Y; Li C; Shao R; Yu H; Zhang Q
Thromb Res; 2018 Nov; 171():149-154. PubMed ID: 30312800
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers.
Niedźwiecki S; Stepień T; Kopeć K; Kuzdak K; Komorowski J; Krupiński R; Stepień H
Cytokine; 2006 Dec; 36(5-6):291-5. PubMed ID: 17374490
[TBL] [Abstract][Full Text] [Related]
19. The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients.
Algaba A; Linares PM; Encarnación Fernández-Contreras M; Figuerola A; Calvet X; Guerra I; de Pousa I; Chaparro M; Gisbert JP; Bermejo F
Inflamm Bowel Dis; 2014 Apr; 20(4):695-702. PubMed ID: 24562175
[TBL] [Abstract][Full Text] [Related]
20. Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia.
Schliemann C; Bieker R; Thoennissen N; Gerss J; Liersch R; Kessler T; Büchner T; Berdel WE; Mesters RM
Leukemia; 2007 Sep; 21(9):1901-6. PubMed ID: 17597808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
